Medicine by Design’s Pivotal Experiment Fund invests $1 million in four research teams to bridge the “valley of death” funding gap

Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.

New research shows diabetes drug could provide brain protection to children who get radiation for brain tumours

Thanks to funding from Medicine by Design, a University of Toronto scientist and her team are closer to finding a way to protect the brain from damage for children who must be treated with cranial radiation.

U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer

Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated

Medicine by Design to accelerate regenerative medicine discovery and translation with new $20-million investment

Projects to advance stem cell and gene therapy, enhance understanding of how the body repairs itself, and generate new technologies that will propel the field for decades

Go to Top